Healthcare Finance Staff
An increasingly popular strategy in drug plan affordability is again coming under scrutiny from Medicare regulators concerned that some urban seniors are being left out.
17 companies on the Fortune list were either healthcare providers, healthcare services firms or biotech firms.
Health insurers and patients could get a bit of relief after years of paying more and more for biologic speciality pharmaceuticals, but some think there are still barriers to affordability.
One of the Bay Area's most popular health systems is expanding its new health plan, trying to craft a unique value proposition in changing times and picking up some notable clients along the way.
The nation's fourth largest insurer is calling on the leader of its flagship plan to manage technology and services across its regions, while ushering in a new president at the 7 million member company.
After transitioning from tax-exempt nonprofit to a tax-paying, mutually-owned company, Michigan's largest health insurer is in pretty good financial health.
Middle-age American men have been aggressively marketed treatments for low testosterone, despite risks and skepticism about benefits. Now insurers have another reason to strictly control coverage.
In the state with the highest per-capita healthcare spending, most of the mainstay insurers spent the last year struggling to harvest operating income.
One of the largest Blue Cross insurers in the American South has taken its first loss in 15 years, showing the challenges of the two main growth areas, ACA plans and Medicare Advantage.
Health insurers treading in legacy business processes are turning to contractors for help ply the new waters of reform, fueling an $8 billion market of its own.